DP

Diadema Partners Portfolio holdings

AUM $168M
1-Year Est. Return 163.97%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+163.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
-$17.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
128
New
Increased
Reduced
Closed

Top Buys

1
+$13.9M
2
+$6.07M
3
+$5.32M
4
ASND icon
Ascendis Pharma
ASND
+$5.14M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.07M

Top Sells

1
+$14.5M
2
+$11M
3
+$10.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$9.76M
5
SLNO icon
Soleno Therapeutics
SLNO
+$7.92M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
76
Amgen
AMGN
$203B
– –
-52,100
APLT
77
DELISTED
Applied Therapeutics
APLT
– –
0
ARVN icon
78
Arvinas
ARVN
$858M
– –
-96,455
AUPH icon
79
Aurinia Pharmaceuticals
AUPH
$1.87B
– –
0
JBIO
80
Jade Biosciences
JBIO
$696M
– –
0
AVXL icon
81
Anavex Life Sciences
AVXL
$420M
– –
0
BBIO icon
82
BridgeBio Pharma
BBIO
$12.5B
– –
0
BHVN icon
83
Biohaven
BHVN
$1.57B
– –
0
BMEA icon
84
Biomea Fusion
BMEA
$96.9M
– –
0
CAPR icon
85
Capricor Therapeutics
CAPR
$1.41B
– –
0
CCCC icon
86
C4 Therapeutics
CCCC
$286M
– –
0
CORT icon
87
Corcept Therapeutics
CORT
$3.83B
– –
0
CRDF icon
88
Cardiff Oncology
CRDF
$131M
– –
0
CRMD icon
89
CorMedix
CRMD
$568M
– –
0
TECX
90
Tectonic Therapeutic
TECX
$430M
– –
0
MBX
91
MBX Biosciences
MBX
$1.37B
– –
0
UPB
92
Upstream Bio Inc
UPB
$416M
– –
0
ETNB
93
DELISTED
89bio
ETNB
– –
-98,382
FOLD icon
94
Amicus Therapeutics
FOLD
$4.51B
– –
0
GILD icon
95
Gilead Sciences
GILD
$184B
– –
-30,000
GOSS icon
96
Gossamer Bio
GOSS
$109M
– –
0
INCY icon
97
Incyte
INCY
$19.9B
– –
0
IONS icon
98
Ionis Pharmaceuticals
IONS
$13.3B
– –
0
ITOS
99
DELISTED
iTeos Therapeutics
ITOS
– –
-206,200
KOD icon
100
Kodiak Sciences
KOD
$1.61B
– –
0
2 3
4
5 6